China Neurology Devices Market Opportunities, Industry 2031

China Neurology Devices Market Opportunities, Industry 2031

Segments - China Neurology Devices Market by Types (Cerebrospinal Fluid Management Device, Interventional Neurology Device, Neurosurgery Device, Neurostimulation Device, and Others), End-users (Hospitals, Ambulatory Surgery Centers, and Neurology Clinics) and Country (China) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031.

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-2451 | 4.6 Rating | 74 Reviews | 195 Pages | Format : PDF Excel PPT

Report Description


The China neurology devices market size was valued at USD 1.01 Billion in 2022 and is anticipated to reach USD 2.25 Billion by 2031, expanding at a CAGR of 9.3% during the forecast period, 2023 – 2031. The growth of the market is attributed to the increasing number of neurological diseases, rising investment in neuroscience equipment by private agents, and the growth of R&D in neuro therapies.

China Neurology Devices Market Outlook

Neurological equipment helps in early detection of various neurological diseases to help prevent Alzheimer’s disease, major depression, spinal cord injury, acute ischemic stroke, traumatic brain injury, and other diseases. These devices represent minimally invasive based technology.

Neurological devices are usually used in complex neurological cases, such as acute ischemic stroke, and are recommended for minimally invasive treatment. Compared to drug thrombolysis, these devices have potential advantages, such as faster recanalization and lower bleeding risk.


The Covid-19 pandemic affected the demand and supply of China neurology devices market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

  • Increasing investment in pharmaceutical and biotechnology industry is anticipated to boost the market during the forecast period.
  • Rapid growth of the healthcare industry due to increasing geriatric population is the major factors fueling the market during the forecast period.
  • Growing demand for minimally invasive surgeries and improvement in healthcare infrastructure is projected to drive the market during forecast period.
  • High cost of neurological treatments and devices is anticipated to restrict the market growth.
  • Implementations of strict regulations by government on neurological devices act as major challenges that can hamper the market growth during the forecast period.
  • R&D investment and technological advancement of neurological devices for easy and minimally invasive diagnosis of neurological disorders is expected to offer immense opportunities for the market players.

Scope of Neurology Devices Market Report

The report on the China neurology devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Neurology Devices Market - China Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Types (Cerebrospinal Fluid Management Device, Interventional Neurology Device, Neurosurgery Device, Neurostimulation Device, and Others), End-users (Hospitals, Ambulatory Surgery Centers, and Neurology Clinics)

Country Scope

China

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Abbott Laboratories; B. Braun Melsungen AG; Boston Scientific Corporation; Johnson and Johnson; Medtronic PLC; MicroPort Scientific; Nihon Kohden Corporation; Smith & Nephew plc; and Stryker Corporation.

China Neurology Devices Market Segment Insights

The cerebrospinal fluid management device segment holds a major market share

Based on types, the China neurology devices market is segregated into cerebrospinal fluid management devices, interventional neurology devices, neurosurgery device, neurostimulation device, and others. The cerebrospinal fluid management device segment is anticipated to expand at a rapid pace. The CSF imbalance can cause an increase in intracranial pressure (ICP), which can cause a variety of symptoms. In recent years, there has been tremendous development in the diagnosis and treatment of neurological illnesses, which is projected to drive market the market during forecast period.

China Neurology Devices Market Types Segmentation

The hospitals segment is anticipated to expand at a substantial CAGR

Based on end users, the China neurology devices market is segregated into hospitals, ambulatory surgery centers, and neurology clinics. The hospital segment accounts for a significant share of the market. Growth of the market is attributed to increasing prevalence of neurological disorders and rapid advancement in neurology devices

On the other hand, the ambulatory surgery centers segment is anticipated to expand at a rapid pace during the forecast period due to increasing inclination of patients for minimally invasive medical procedures, the increasing number of outpatient surgery centers in developed countries, and convenience of programming in these centers, professional clinical staff, increased productivity, and increased safety and efficiency.

China Neurology Devices Market End-User Segmentation

Segments

The China neurology devices market is segmented on the basis of

Types

  • Photoelectric
  • Dual-sensor
  • Ionization

End-users

  • Hospitals
  • Ambulatory Surgery Centers
  • Neurology Clinics

Country

  • China

Key Players

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Johnson and Johnson
  • Medtronic PLC
  • MicroPort Scientific
  • Nihon Kohden Corporation
  • Smith & Nephew plc
  • Stryker Corporation

Competitive Landscape

Major players competing in the China neurology devices market include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, MicroPort Scientific, Nihon Kohden Corporation, Smith & Nephew plc, and Stryker Corporation.
Some of these players are using several market strategies including mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

China Neurology Devices Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neurology Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Neurology Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Neurology Devices Market - Supply Chain
  4.5. Global Neurology Devices Market Forecast
     4.5.1. Neurology Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Neurology Devices Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Neurology Devices Market Absolute $ Opportunity
5. Global Neurology Devices Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Neurology Devices Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Neurology Devices Demand Share Forecast, 2019-2026
6. North America Neurology Devices Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Neurology Devices Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Neurology Devices Demand Share Forecast, 2019-2026
7. Latin America Neurology Devices Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Neurology Devices Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Neurology Devices Demand Share Forecast, 2019-2026
8. Europe Neurology Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Neurology Devices Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Neurology Devices Demand Share Forecast, 2019-2026
9. Asia Pacific Neurology Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Neurology Devices Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Neurology Devices Demand Share Forecast, 2019-2026
10. Middle East & Africa Neurology Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Neurology Devices Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Neurology Devices Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Neurology Devices Market: Market Share Analysis
  11.2. Neurology Devices Distributors and Customers
  11.3. Neurology Devices Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Abbott Laboratories
     11.4.2. B. Braun Melsungen AG
     11.4.3. Boston Scientific Corporation
     11.4.4. Johnson and Johnson
     11.4.5. Medtronic PLC
     11.4.6. MicroPort Scientific
     11.4.7. Nihon Kohden Corporation

Methodology

Our Clients

Honda Motor Co. Ltd.
Deloitte
Siemens Healthcare
The John Holland Group
Pfizer
General Mills
Nestle SA
General Electric